全文获取类型
收费全文 | 469篇 |
免费 | 102篇 |
出版年
2021年 | 8篇 |
2020年 | 4篇 |
2019年 | 4篇 |
2018年 | 8篇 |
2016年 | 10篇 |
2015年 | 15篇 |
2014年 | 19篇 |
2013年 | 20篇 |
2012年 | 24篇 |
2011年 | 38篇 |
2010年 | 15篇 |
2009年 | 16篇 |
2008年 | 30篇 |
2007年 | 20篇 |
2006年 | 19篇 |
2005年 | 13篇 |
2004年 | 23篇 |
2003年 | 27篇 |
2002年 | 20篇 |
2001年 | 11篇 |
2000年 | 14篇 |
1999年 | 15篇 |
1998年 | 6篇 |
1997年 | 6篇 |
1996年 | 5篇 |
1994年 | 4篇 |
1993年 | 8篇 |
1992年 | 9篇 |
1991年 | 7篇 |
1990年 | 13篇 |
1989年 | 10篇 |
1988年 | 5篇 |
1987年 | 8篇 |
1986年 | 6篇 |
1985年 | 5篇 |
1984年 | 7篇 |
1983年 | 8篇 |
1980年 | 5篇 |
1979年 | 5篇 |
1978年 | 8篇 |
1976年 | 3篇 |
1975年 | 4篇 |
1974年 | 5篇 |
1973年 | 5篇 |
1972年 | 3篇 |
1971年 | 11篇 |
1969年 | 5篇 |
1968年 | 3篇 |
1956年 | 4篇 |
1953年 | 3篇 |
排序方式: 共有571条查询结果,搜索用时 218 毫秒
1.
2.
3.
4.
5.
Doris Hillemann Sven Hoffner Daniela Cirillo Francis Drobniewski Elvira Richter Sabine Rüsch-Gerdes the Baltic-Nordic TB- Laboratory Network TB PAN-NET ECDC ERLN-TB Networks 《PloS one》2013,8(10)
Three networks/projects involving 27 European countries were established to investigate the quality of second-line drug (SLD) susceptibility testing with conventional and molecular methods. 1. The “Baltic-Nordic TB-Laboratory Network” comprised 11 reference laboratories in the Baltic-Nordic States. They performed SLD testing in the first phase with a panel of 20 Mycobacterium tuberculosis strains. After several laboratories made technical changes a second panel of 10 strains with a higher proportion of resistant strains were tested. Although the concordance for Ofloxacin, Kanamycin, and Capreomycin was consistently high, the largest improvements in performance were achieved for the analysis of Ofloxacin resistant (from 88.9 to 95.0%), and Capreomycin resistant (from 71.0 to 88.9%) strains. 2. Within the FP7 TB PAN-NET project (EU Grant agreement 223681) a quality control panel to standardize the EQA (External Quality Assurance) for first-line drugs (FLD) and SLD testing for phenotypic and molecular methods was established. The strains were characterized by their robustness, unambiguous results when tested, and low proportion of secondary drug resistances. 3. The (European Reference Laboratory Network-TB) ERLN-TB network analyzed four different panels for drug resistance testing using phenotypic and molecular methods; in two rounds in 2010 the 31 participating laboratories began with 5 strains, followed by 10 strains and 6 additional crude DNA extracts in 2011 and 2012 were examined by conventional DST and molecular methods. Overall, we demonstrated the importance of developing inter-laboratory networks to establish quality assurance and improvement of SLD testing of M. tuberculosis. 相似文献
6.
R. Hecht T. Tressel V. Goldshteyn D. Winters J. Wilson T. Boone 《Preparative biochemistry & biotechnology》2013,43(3-4):201-216
Abstract This paper presents a case study of using a multicompartment isoelectric focusing apparatus to determine the isoelectric points and focus preparative quantities of brain derived neurotrophic factor (BDNF) and neurotrophic factor 3 (NT3). A separation of PEGylated from unPEGylated forms of granulocyte colony stimulating factor (G-CSF) is described as well. Both BDNF and NT3 have substantially higher pI values in this system than is predicted from sequenced based modeling. Although PEGylated forms of G-CSF can be separated from the unPEGylated forms, separation of protein with differing degrees of PEGylation was not achieved. The paper additionally demonstrates that this technique can be used simultaneously as an analytical and preparative tool, eliminating the need for analytical IEF gels. 相似文献
7.
Harold D. Love S. Erin Booton Braden E. Boone Joan P. Breyer Tatsuki Koyama Monica P. Revelo Scott B. Shappell Jeffrey R. Smith Simon W. Hayward 《PloS one》2009,4(12)
Benign prostatic hyperplasia (BPH) and prostate carcinoma (CaP) are linked to aging and the presence of androgens, suggesting that androgen regulated genes play a major role in these common diseases. Androgen regulation of prostate growth and development depends on the presence of intact epithelial-stromal interactions. Further, the prostatic stroma is implicated in BPH. This suggests that epithelial cell lines are inadequate to identify androgen regulated genes that could contribute to BPH and CaP and which could serve as potential clinical biomarkers. In this study, we used a human prostate xenograft model to define a profile of genes regulated in vivo by androgens, with an emphasis on identifying candidate biomarkers. Benign transition zone (TZ) human prostate tissue from radical prostatectomies was grafted to the sub-renal capsule site of intact or castrated male immunodeficient mice, followed by the removal or addition of androgens, respectively. Microarray analysis of RNA from these tissues was used to identify genes that were; 1) highly expressed in prostate, 2) had significant expression changes in response to androgens, and, 3) encode extracellular proteins. A total of 95 genes meeting these criteria were selected for analysis and validation of expression in patient prostate tissues using quantitative real-time PCR. Expression levels of these genes were measured in pooled RNAs from human prostate tissues with varying severity of BPH pathologic changes and CaP of varying Gleason score. A number of androgen regulated genes were identified. Additionally, a subset of these genes were over-expressed in RNA from clinical BPH tissues, and the levels of many were found to correlate with disease status. Our results demonstrate the feasibility, and some of the problems, of using a mouse xenograft model to characterize the androgen regulated expression profiles of intact human prostate tissues. 相似文献
8.
9.
10.
Darren Boone Susan Mallett Justine McQuillan Stuart A. Taylor Douglas G. Altman Steve Halligan 《PloS one》2015,10(9)